Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Technical brief | 03 July 2025 HIV/AIDS Intellectual property and trade Gilead’s Voluntary License on Lenacapavir: Key Limitations of the License and Recommendations to Improve Access
Technical brief | 02 July 2025 Tuberculosis Bridging the gap: Securing access to essential TB medicines in the EU and EEA
Photo Credit: Dorine Niyungeko/MSF Press release Press release | 26 June 2025 Vaccines Following Gavi’s replenishment, MSF calls for vaccine access for children in humanitarian settings 2 min
Photo Credit: Bafana Ngwenya/MSF 12 June 2025 Diabetes MSF welcomes Novo Nordisk’s commitment to supply South Africa with analogue insulin pens, but the price must come down to $1 per pen 3 min
Photograph by WHO/Pierre Albouy Events Events | 19 May 2025 MSF at the 78th World Health Assembly 1 min
Copyright: Stefan Heunis Press release Press release | 15 May 2025 HIV/AIDS Tuberculosis South AfricaUnited States of America US funding cuts threaten 39 research sites in South Africa, putting scientific advancements and hard-won progress against TB and HIV at risk 5 min
Report | 15 May 2025 HIV/AIDS Research and development South AfricaUnited States of America South Africa’s TB and HIV Research at Risk : A Call To Catalyze Urgent Action By Funders
Photograph by Alexandra Sadokova Press release Press release | 24 April 2025 Transparency Call for transparency: detailed cost analysis of MSF’s TB-PRACTECAL clinical trial in PLOS Global Public Health 2 min
